200
Participants
Start Date
April 10, 2022
Primary Completion Date
February 28, 2023
Study Completion Date
March 1, 2023
Cytoflavin (succinic acid + inosine + nicotinamide + riboflavin)
10 ml diluted to 100-200 ml of 5-10% dextroseor 0.9% sodium chloride solution. The rate of administration is 3-4 ml / min. The drug is administered in a volume of 10 ml per injection with an interval of 8-12 hours for 10 days. In severe cases of the disease, a single dose is increased to 20 ml.
Control
Standard treatment accordind to the routine clinical practice
City Hospital of the Holy Martyr Elizabeth, Saint Petersburg
Northern State Medical University of the Ministry of Health of the Russian Federation, Arkhangelsk
Belgorod Regional Clinical Hospital of St. Joasaph, Belgorod
Interregional Clinical and Diagnostic Center, Kazan'
City General Hospital №2, Saint Petersburg
City Mariinsky Hospital, Saint Petersburg
"SPb GBUZ City Hospital №26", Saint Petersburg
POLYSAN Scientific & Technological Pharmaceutical Company
INDUSTRY